GURUFOCUS.COM » STOCK LIST » USA » NYSE » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Cash-to-Debt
Switch to:

Nuvation Bio Cash-to-Debt

: 149.97 (As of Jun. 2022)
View and export this data going back to 2021. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Nuvation Bio's cash to debt ratio for the quarter that ended in Jun. 2022 was 149.97.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Nuvation Bio could pay off its debt using the cash in hand for the quarter that ended in Jun. 2022.

The historical rank and industry rank for Nuvation Bio's Cash-to-Debt or its related term are showing as below:

NUVB.WS' s Cash-to-Debt Range Over the Past 10 Years
Min: 149.97   Med: No Debt   Max: No Debt
Current: 149.97

During the past 2 years, Nuvation Bio's highest Cash to Debt Ratio was No Debt. The lowest was 149.97. And the median was No Debt.

NUVB.WS's Cash-to-Debt is ranked better than
77.37% of 1560 companies
in the Biotechnology industry
Industry Median: 10.66 vs NUVB.WS: 149.97

Nuvation Bio Cash-to-Debt Historical Data

The historical data trend for Nuvation Bio's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Annual Data
Trend Dec20 Dec21
Cash-to-Debt
No Debt 250.54

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Cash-to-Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt 250.54 264.88 149.97

Competitive Comparison

For the Biotechnology subindustry, Nuvation Bio's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Nuvation Bio Cash-to-Debt Distribution

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Cash-to-Debt falls into.



Nuvation Bio Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nuvation Bio's Cash to Debt Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Nuvation Bio's Cash to Debt Ratio for the quarter that ended in Jun. 2022 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB.WS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Nuvation Bio Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio Business Description

Nuvation Bio logo
Traded in Other Exchanges
Address
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)